Zhonghui Gai
Department of Research and Development, Wecare Probiotics (Suzhou) Co., Ltd., Suzhou, China
- Papers in database
- 8
- Primary author
- 1 paper
- Years active
- 2023 – 2025
- Health outcomes studied
- 3
Health Outcomes Studied
Papers (8)
- 2025Genome sequence and evaluation of safety and probiotic potential of <i>Lacticaseibacillus paracasei</i> LC86 and <i>Lacticaseibacillus casei</i> LC89.10.3389/fmicb.2024.1501502
- 2025Protective effects of Bifidobacterium longum subsp. longum BL21 against cyclophosphamide-induced reproductive dysfunction in zebrafish.10.1038/s41598-025-97721-w
- 2025Efficacy and Safety of <i>Lactobacillus acidophilus</i> LA85 in Preventing Antibiotic-Associated Diarrhea: A Randomized, Placebo-Controlled Study.10.1002/fsn3.70490
- 2024<i>Lacticaseibacillus rhamnosus</i> LRa05 mediates dynamic regulation of intestinal microbiota in mice with low-dose DSS-induced chronic mild inflammation.10.3389/fmicb.2024.1483104
- 2023Utilization of diverse oligosaccharides for growth by Bifidobacterium and Lactobacillus species and their in vitro co-cultivation characteristics.10.1007/s10123-023-00446-x
- 2023Primary authorChanges in the gut microbiota composition of healthy young volunteers after administration of Lacticaseibacillus rhamnosus LRa05: A placebo-controlled study10.3389/fnut.2023.1105694
- 2023Sustained ameliorative effect of Lactobacillus acidophilus LA85 on dextran sulfate sodium-induced colitis in mice.10.1111/1750-3841.16723
- 2023Lacticaseibacillus rhamnosus Hao9 exerts antidiabetic effects by regulating gut microbiome, glucagon metabolism, and insulin levels in type 2 diabetic mice10.3389/fnut.2022.1081778